Bonafide Health acquired by Pharmavite
Pharmavite acquired Bonafide Health, a women's health supplements brand, on Nov 30, 2023.
Transaction summary
- Target
- Bonafide Health
- Acquirer
- Pharmavite
- Seller
- -
- Announced
- 2023-11-30
- Geography
- -
- Tags
- CPGMenopause SupportWomen'S Health Supplements
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
100% enterprise value
USD 425M
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Consideration: USD 425M
Google News result title for Business Wire dated 2023-11-30 states Pharmavite announced a $425 million acquisition of Bonafide Health; WWD and other headline results also state $425 million.
Basis
- USD 425m consideration is treated as publicly disclosed or derived directly from public source data.
- Valuation covers 100% of the target; the amount invested or paid for a stake is separate.
Source summary
No public source summary has been published for this transaction yet.